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Background
Variceal recurrence following endoscopic treatment is very common and associated with the variceal bleeding or rebleeding 
risk. Esophageal collateral veins are observed by endoscopic ultrasound (EUS) in patients with portal hypertension. The aim 
of the study was to identify whether EUS findings could predict the early variceal recurrence after endoscopic band ligation 
(EBL). 
Patients and methods
The prospective cohort study was performed, including consecutive patients, undergoing EBL for esophageal varices. EUS 
was performed before ligation, and the type and grade of esophageal collateral veins (ECV) were described. After all EBL ses-
sions had been completed, patients were examined every three months for a 12-month period to detect variceal recurrence. 
Patients in whom varices reoccurred within six months were noted as the early recurrence group. The relationship between 
the type and grade of ECV and the early variceal recurrence was analysed to detect the possible risk factors. The study was 
approved by the local ethics committee.
Results
Forty patients were included in the study over the study period. Twelve of the forty patients (30%) had early variceal recur-
rence within six months, and nineteen of the forty patients (47.5%) had variceal recurrence within twelve months after EBL. 
Overall, the mean number of months from the end of EBL until recurrence was 7.26 ± 3.05 (3–12)). Severe peri-ECV were statis-
tically significantly associated with the higher variceal recurrence risk within six months (p = 0.041), whereas severe para-ECV 
had no statistically significant risk related to the early variceal recurrence risk (p = 0.149). 
Conclusions
A positive association between early variceal recurrence following endoscopic band ligation and specific findings on EUS was 
demonstrated. Severe-grade peri-ECV predict early variceal recurrence following EBL.
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Įvadas / tikslas
Pagrindinis stemplės venų varikozės gydymo metodas yra endoskopinis jų perrišimas guminiais žiedais (toliau – endoskopi-
nis perrišimas). Stemplės venų varikozės atsinaujinimas po endoskopinio gydymo yra dažnas ir jam būdingas didelis krau-
javimo pavojus. Sergant kepenų ciroze su portine hipertenzija, aplink stemplę išsiplečia kolateralinės venos, kurias galima 
matyti ir įvertinti atliekant endoskopinį ultragarsinį tyrimą. Šio darbo tikslas – nustatyti, ar endoskopinio ultragarsinio tyrimo 
metu matomas kolateralinių venų tipas ir dydis gali padėti prognozuoti ankstyvą stemplės venų varikozės atsinaujinimą po 
endoskopinio perrišimo.
Ligoniai ir metodai
Į prospektyvųjį tyrimą įtraukti ligoniai, kuriems buvo atliktas stemplės varikozinių venų endoskopinis perrišimas. Prieš 
perrišimą visiems pacientams buvo atliktas endoskopinis ultragarsinis tyrimas ir įvertintas aplink stemplę esančių venų ti-
pas ir dydis. Po endoskopinio stemplės varikozinių venų perrišimo ligoniai buvo stebimi vienerius metus siekiant nustatyti 
stemplės venų varikozės atsinaujinimą. Atsinaujinimas, kuris išsivystė per 6 mėnesius po gydymo, buvo vadinamas ankstyvu. 
Siekiant nustatyti ankstyvo stemplės venų varikozės atsinaujimo rizikos veiksnius, buvo įvertintas kolateralinių venų ryšys su 
atsinaujinimu. Tyrimui atlikti buvo gautas regioninio biomedicininių tyrimų etikos komiteto leidimas.
Rezultatai
Po endoskopinio perrišimo 30 % pacientų  (12 iš 40) išsivystė ankstyvas stemplės  venų varikozės atsinaujimas. Didelės ar-
timosios (peri) kolateralinės venos, diagnozuojamos atliekant endoskopinį ultragarsinį tyrimą, buvo statistiškai reikšmingai 
susijusios su didesne ankstyvo stemplės  venų varikozės atsinaujimo rizika (p=0,041). Didelės tolimosios (para) kolateralinės 
venos, diagnozuojamos atliekant endoskopinį ultragarsinį tyrimą, nebuvo statistiškai reikšmingai susijusios su didesne 
ankstyvo atsinaujimo rizika (p=0,149).
Išvados
Šiuo tyrimu nustatyta, kad didelės artimosios kolateralinės venos yra susijusios su ankstyvu  stemplės venų varikozės atsinau-
jimu po endoskopinio perrišimo.
Reikšminiai žodžiai: endoskopinis ultragasinis tyrimas, stemplės venų varikozės atsinaujimas, endoskopinis perrišimas
Introduction
Gastroesophageal varices are the most relevant por-
tosystemic collaterals in portal hypertension. Variceal 
bleeding is the most severe complication of cirrhosis 
and is related with a high mortality rate among these 
patients. The mortality rate in each episode is up to 30% 
[1] and 15–20% at six weeks [2, 3]. Recurrent bleeding 
is common without prophylactic treatment [4], indica-
ting that the treatment of esophageal varices should be 
aimed at preventing variceal recurrence and rebleeding. 
Many kinds of collaterals develop in patients with portal 
hypertension for the reduction of a high portal pressure 
[5, 6, 7]. The detailed mechanism of variceal recurrence 
after endoscopic treatment is still not fully identified, 
but it seems to be related with these collateral veins.
Endoscopic band ligation (EBL) became the pre-
ferred method of treatment for esophageal varices, 
because it was proved in several randomized trials to be 
as effective as injection sclerotherapy with fewer serious 
adverse events, requiring fewer sessions to achieve eradi-
cation, but related to a higher frequency of recurrent 
varices as compared with sclerotherapy [8, 9]. However, 
the recurrence of esophageal varices occurs, and the 
recurrence is associated with the variceal rebleeding 
risk. The reported rates of variceal recurrence after EBL 
range between 8–48% [10–12]. Since variceal recur-
rence following endoscopic treatment is inevitable, the 
determination of risk factors contributing to it may be 
of clinical significance. 
The systematic analysis [13] of 13 studies analy-
sing gastroesophageal collateral veins as risk factors for 
variceal recurrence after endoscopic treatment showed 
that perforating veins and periesophageal collateral veins 
were related to a higher risk of variceal recurrence (OR = 
3.93; 95 % CI 1.06–14.51; I2 = 96 %; OR = 2.29; 95 % 
CI 1.58–3.33; I2 = 55 %). These findings should be 
interpreted with caution because of the heterogeneity of 
the studies with regard to the method of treating varices, 
the time index when EUS was performed, the recorded 
EUS parameters, definitions of collateral veins, and the 
follow-up length. Only a few prospective studies with 
a small sample size evaluating the EUS risk factors for 
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variceal recurrence following endoscopic band ligation 
have been published [14–17]. 
The aim of the present study was to evaluate whether 
the type and grade of esophageal collateral veins detect-
ed by EUS can predict the early recurrence of esophageal 
varices in patients treated by EBL.
Patients and methods
Inclusion / exclusion criteria
Patients with esophageal varices treated by EBL from 
September 2011 to June 2013 were prospectively en-
rolled in this cohort study. The inclusion criteria were 
as follows: (1) aged over 18 years; (2) liver cirrhosis with 
intrahepatic portal hypertension; (3) size of varices F2 or 
F3 according to the recommendations of the Japanese 
society for portal hypertension [18]; (4) primary or 
secondary variceal prophylaxis according to the Baveno 
V consensus [19]; (5) signed informed consent. The 
exclusion criteria were as follows: (1) age younger than 
18 years; (2) refusal to participate in the study; (3) 
hepatocellular carcinoma stage C according to the Bar-
celona Clinic Liver Cancer classification [20]; (4) type 
1 hepatorenal syndrome; (5) grade 3–4 of hepatic en-
cephalopathy; (6) pregnancy; (7) severe comorbidities. 
The study was approved by the local ethics committee.
Pre-treatment evaluation included a detailed medical 
history, physical examination and the patients’ age, gen-
der, aetiology of liver cirrhosis and episodes of previous 
variceal bleeding. The use of non-selective beta-blockers 
was noted. Child–Pugh’s score and the MELD (Model 
of end-stage liver disease) score were also estimated. A 
complete blood count, liver function tests, kidney func-
tion tests and abdominal ultrasound were carried out. 
Conventional endoscopy and endoscopic ultrasound 
had been performed before endoscopic band ligation. 
Patients received local oropharyngeal anaesthesia and 
intravenous sedation before endoscopic examinations. 
Conventional endoscopy
Upper gastrointestinal endoscopy was performed to 
examine the esophagus for submucosal varices. The 
endoscopy had been performed before EUS and EBL 
in all patients with Olympus Evis Exera II videoendo-
scopes GIF–Q165 or GIF-H180. Esophageal varices 
were evaluated according to the recommendations of the 
Japanese society for portal hypertension: localization, 
colour, size (F1, F2, F3), and the presence of red colour 
signs (RCS). The size of the varices was determined 
during withdrawal of the endoscope; also, as much air 
as possible was aspirated from the stomach while the 
esophageal lumen was fully inflated. 
Endoscopic ultrasound (EUS)
Before EBL, all patients had undergone an EUS exami-
nation using a radial echoendoscope with the frequency 
of 12 MHz (Olympus GF-UE 160-AL5). EUS was per-
formed by an independent endoscopist who was blinded 
to the patients’ clinical data as well as to the results of 
conventional endoscopy. During the EUS examination, 
the presence of extra-luminal esophageal collateral veins 
was determined. Collaterals around the esophagus were 
scanned from the esophago-gastric junction, withdraw-
ing the echoendoscope to the 5th proximal centimetre. 
Based on EUS findings, esophageal collateral veins 
(ECV) were classified into two types: peri-ECV and 
para-ECV (Fig. 1). The corresponding EUS images 
depicting peri-ECV and para-ECV are presented in Fig. 
2. Peri-ECV were described as a group of small vessels 
adjacent to the muscularis propria layer. Para-ECV were 
described as a group of larger vessels away from the mus-
cularis propria layer. Peri-ECV were classified as none, 
Fig. 1. Esophageal collateral veins detected by EUS: schematic 
picture
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mild (<2 mm) or severe (≥2 mm), and para-ECV were 
also classified as none, mild (<5 mm) or severe (≥5 mm). 
Endoscopic band ligation and observation
The standard ligation technique was followed and multi-
band EBL device was used (Super7, Boston Scientific). 
EBL was repeated at 2-week intervals until esophageal 
varices were eradicated. The eradication of varices was 
defined as non-visualization of varices in the distal es-
ophagus or as varices too small for ligation. 
After all EBL sessions had been completed, patients 
were observed for variceal recurrence and upper gastro-
intestinal endoscopy every three months until 12 months 
after the procedure had been performed. Recurrence of 
esophageal varices was defined as either the formation of 
new varices or the appearance of RCS. Patients in whom 
varices reoccurred within six months were as ascribed to 
the early recurrence group. The relationship between the 
EUS findings prior to EBL and the esophageal varices 
recurrence rate and time was analysed. The flow diagram 
of the study is depicted in Fig. 3.
Statistical analysis
Continuous variables are presented as mean and stand-
ard deviations. Student’s t-test or the Mann–Whitney U 
test were used to compare the mean differences among 
the groups. Categorical variables were analysed by the 
Chi-square or Fisher’s exact tests. The recurrence-free 
survival curve was generated using the Kaplan–Meier 
method. The statistical analyses were performed with 
an SPSS program (v17). A p value of less than 0.05 was 
considered statistically significant. 
Results
During the study period, forty patients (28 men (70%) 
and 12 women (30%) with the average age of 54.1 ± 9 
years, range 35–77 years, were enrolled in this prospective 
study. The cause of portal hypertension in all patients was 
alcohol-related liver cirrhosis (47.5%, n = 19), namely 
hepatitis C cirrhosis (37.5%, n = 15), primary biliary 
cirrhosis (5%, n = 2) and cryptogenic liver cirrhosis (10%, 
Fig. 2. EUS images: peri-ECV (short arrows) and para-ECV 
(long arrow)
Fig. 3. The flow diagram of the study
Patients with liver cirrhosis 
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165Endoscopic ultrasound predicts early recurrence of esophageal varices after endoscopic band ligation: a prospective cohort study
n = 4). The main indication for EBL was secondary prop-
hylaxis (57.5%, n = 23), followed by primary prophylaxis 
(42.5%, n = 17). The size of the varices before treatment 
was F2 in 24 patients (60%) and F3 in 16 patients (40%), 
and 77.5% of them had RCS. Overall, we performed 
89 EBL procedures and placed 422 rubber bands. The 
mean number of bands placed during the one EBL ses-
sion was five (range, 2–9), and the mean number of EBL 
sessions to achieve variceal obliteration was 2.13 ± 0.82 
(range, 1–5). All patients achieved variceal eradication 
and were regularly checked for recurrence following EBL 
throughout the one-year period.
During the follow-up period, 19 patients had variceal 
recurrence (47.5%). The mean number of months from 
the end of EBL until variceal recurrence was 7.26 ± 3.05 
(range, 3–12). Recurrence of esophageal varices was de-
tected in 3 (7.5%) of the 40 patients within three months, 
in 12 (30%) within six months, in 15 (37.5%) within is-
nine month, and in 19 (47.5%) of the 40 patients within 
one year of EBL. 21 patient were recurrence-free after one 
year. The recurrence-free survival curve was generated by 
the Kaplan–Meier method and is presented in Fig. 4.
Regarding the recurrence of esophageal varices, the 
patients were divided into the early variceal recurrence 
group (n = 12) and the group of recurrence within 12 
months (n = 19). The early variceal recurrence was de-
fined as recurrence within six months or less.
Comparison of EUS findings
The EUS findings obtained prior to EBL were compared 
between the early variceal recurrence group and all pa-
tients who had variceal recurrence within 12 months. 
Severe peri-ECV cases were statistically significantly 
associated with a higher variceal recurrence risk both 
within six months (p = 0.041) and within 12 months 
(p < 0.001). Severe para-ECV cases were statistically 
significantly associated with the higher variceal recur-
rence risk only within 12 months (p = 0.018) and had 
no statistically significant risk related to the early variceal 
recurrence risk within six months (p = 0.149) (Table 1).
Discussion 
Since variceal recurrence following endoscopic treat-
ment is inevitable, the determination of risk factors 
contributing to it is of clinical significance. 
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Table 1. Outcome at 6 and 12 months in patients with non/mild or severe ECV
Non/mild peri-ECV
n = 20
Severe peri-EVC
n = 20
p value Odds ratio
(95% CI)
Recurrence (%):
· within 6 months
· within 12 months
3 (15)
3 (15)
9 (45)
16 (80)
0.041
<0.001
4.64
(1.02–21.00)
22.67
(4.37–117.47)
Non/mild para-ECV
n = 35
Severe para-ECV
n = 5
p value
Odds ratio
(95% CI)
Recurrence (%):
· within 6 months
· within 12 months
9 (25.7)
14 (40)
3 (60)
5 (100)
0.149
0.018
4.33
(0.62–30.25)
16.31
(0.84–318.14)*
* Before calculations, the frequency of 0.5 had been added to all frequencies in 2 × 2 tables whenever a cell was empty.
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The available evidence suggests that the type and grade 
of collateral veins on EUS predisposes to the recurrence 
of esophageal varices after endoscopic treatment. Several 
investigators have pointed out a relationship between 
extra-esophageal collateral veins and the recurrence of 
esophageal varices after endoscopic treatment. It is very 
difcult to analyse and combine the results of these stu-
dies because of their heterogeneity, especially regarding 
the follow-up length and the treatment method of va-
rices. The majority of the studies have analysed variceal 
recurrence and the related EUS risk factors following 
sclerotherpy or a combined endoscopic treatment. Only 
a few of them have analysed variceal recurrence and the 
related EUS risk factors following EBL [14–17]. The 
treatment method is important because the effects of 
sclerotherapy and EBL on esophageal varices are diffe-
rent, which is why studies showed different results for 
the prevalence and predictive value of collateral veins.
Our study has demonstrated that the early variceal 
recurrence after EBL is associated with the presence of a 
severe-grade peri-ECV on EUS before EBL. The results 
of our study coincide with the results of other authors 
who have investigated pre-treatment EUS findings in 
relation with variceal recurrence after EBL. It is difcult 
to compare our results with the results of similar studies 
because of differences regarding the follow-up length 
and the definitions of collateral veins.
 To our knowledge, the last published study about 
the EUS role in predicting variceal recurrence following 
EBL was carried out by Kume et al. in 2012 [14]. They 
have reported that severe esophageal collateral veins 
and perforating veins by EUS before EBL predict a 
long-term endoscopic recurrence of esophageal varices. 
Konishi et al. [15] performed the first study to show 
the importance of pre-treatment EUS in assessing the 
relationship between the cardiac vascular structures 
and the recurrence of esophageal varices after EBL. 
This short-term follow-up study has revealed that the 
presence of severe grade cardiac perforating veins is 
strongly associated with an early (within three months) 
recurrence of esophageal varices following EBL, other 
than those with mild perforating veins (90.9% vs 21%, 
p < 0.01). Leung et al. and Lo et al. [16, 17] reported 
that the rates of recurrent varices and recurrent bleeding 
were significantly higher in patients with the severe-
grade para-ECV. In the latter studies, the para-ECV 
corresponded to the peri-ECV in our study.
Our study had several limitations. A larger sample 
size and a longer follow-up period would be more 
appropriate, but in our case we had some limitations 
regarding the study duration. Another limitation was 
that we had no possibility to use a mini-probe echo-
endoscope with a higher frequency for a more accurate 
evaluation of esophageal collateral veins. The evaluation 
for variceal recurrence after EBL is relatively subjective 
and poses some difculties to the decision whether or 
not esophageal veins have reoccurred. Also, in different 
studies the definitions of variceal recurrence are diffe-
rent. We believe that more objective parameters would 
be more appropriate; for example, the recurrence of 
varices may be defined as varices witch could be ligated. 
On the other hand, this study was the first in Lithuania 
in which we used the EUS as the diagnostic tool for 
portal hypertension. 
The current study presents the information that may 
be important for selecting the optimal treatment for 
esophageal varices. The esophageal varices that show 
mild collateral veins on EUS before EBL may be appro-
priate for EBL. On the other hand, esophageal varices 
with other types of ECV on EUS may be suitable for a 
combined endoscopic treatment. EUS could be used to 
better evaluate the risk of recurrence and rebleeding of 
esophageal varices. It could also help to identify patients 
who are at risk of variceal recurrence and rebleeding and 
to choose the proper endoscopic and/or medical treat-
ment and surveillance according to the risk of variceal 
recurrence. Furthermore, it could be used to approve 
the surveillance protocols and to determine indications 
for EBL or endoscopic sclerotherapy, to reduce morta-
lity and, finally, to prolong the waiting time for liver 
transplantation.
The role of EUS in predicting variceal recurrence after 
endoscopic treatment in patients with portal hyperten-
sion remains to be investigated in future studies, espe-
cially the role of EUS in improving the survival rate of 
patients with esophageal varices. Specific situations in 
which we could strongly recommend using ES have not 
yet been clearly defined. New indications can be develo-
ped in future after an adequate experimental validation.
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Conclusions
A positive association between early variceal recurrence 
after EBL and the type and grade of collateral veins in-
vestigated by EUS has been demonstrated. Severe peri-
ECV have been found to be statistically significantly as-
sociated with the early variceal recurrence risk after EBL. 
EUS is a promising tool for predicting the recurrence of 
esophageal varices following the endoscopic treatment. 
The further research should address the relation between 
EUS and the recurrence of esophageal varices in other 
types of treatment and establish surveillance protocols 
for the recurrence.
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